Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $110.1500 (2.58%) ($108.4900 - $111.1500) on Mon. Jun. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.53% (three month average) | RSI | 44 | Latest Price | $110.1500(2.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -1.9% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.265% in a week (0% probabilities). VXX(-21%) TLT(-15%) IFRA(-8%) UUP(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.265% (StdDev 2.53%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
1 - 5 Day Possible Target | $105.87(-3.89%) | Resistance Level | $114.33 | 5 Day Moving Average | $110.21(-0.05%) | 10 Day Moving Average | $111.76(-1.44%) | 20 Day Moving Average | $114.33(-3.66%) | To recent high | -14.8% | To recent low | 4% | Market Cap | $1.77b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |